September 22nd, 2007 by Richard Brassaw
Researchers at the Taub Institute for Research on Alzheimer’s Disease and the Aging Brain decided to see if there was a genetic link to Parkinson’s disease that thus far has been unrecognized.
They determined the best approach was to focus on the GBA gene. Mutations of this gene had been identified as the cause for Gaucher’s disease, which [...]
September 21st, 2007 by Joe Posner
by Joe Posner
In the 1990s, various films debuted with disabled characters. That’s the good news. The bad news is that the roles tended to be played by able bodied actors, and the portrayals weren’t always positive.
First up, “The Waterdance.” Released in 1992, it was written by Neal Jimenez and directed by Jimenez & Michael Steinberg. [...]
September 21st, 2007 by Richard Brassaw
This past spring the National Institutes of Health (NIH) announced a phase III clinical trial of creatine and its effects on Parkinson’s disease. Creatine is an over-the-counter nutritional supplement found naturally in the body and in red meat and used by body builders to ‘bulk-up.’
Recruitment is still active in many of the research facilities. The [...]
September 20th, 2007 by Richard Brassaw
Ironically, researchers ‘think’ they have an understanding of how we ‘think’ and how memory is created. When it comes to the brain it is a matter of speculation of how our metaphorical gears work.
Recent research by Duke University’s Medical Center neurobiologist, Michael Ehlers, M.D., Ph.D., has filled in one more piece of the puzzle. His [...]
September 19th, 2007 by Richard Brassaw
Currently 5 million Americans suffer from Alzheimer’s disease. That number is expected to increase dramatically as Baby-Boomers move into old age.
Although research has not been able to find a cure for Alzheimer’s, what is known is that treatment is most effective when started in the earliest onset of the disease. Time is truly an enemy [...]
September 18th, 2007 by Richard Brassaw
A common practice among health-care professionals is to determine the severity of a patient’s pain by asking them to rate their pain from 0 (no pain) to 10 (worst pain). It’s a quick and easy way, but research indicates it may not be reliable.
Until now no one has bothered to evaluate the accuracy of the [...]
September 17th, 2007 by Richard Brassaw
Currently, over 20 drugs are in development for the treatment of fibromyalgia. That number is expected to grow in the next year.
At present, the only drug to be approved for the treatment of fibromyalgia, by the FDA, is Lyrica. Sales of Lyrica are expected to reach $641 million in 2016 according the business forecasting company [...]
September 16th, 2007 by Richard Brassaw
The nematode worm is a favorite subject of medical researchers, because they are transparent. They are also small, very small, being made up of fewer than 1,000 cells. Under the microscope, it is possible to observe neurons die in real time in this lowly worm.
What makes the nematode worm ideal for Parkinson’s disease research is [...]
September 15th, 2007 by Richard Brassaw
Chronic fatigue syndrome (CFS) patients fall into the group of diseases that doctors debate are imagined in the patient’s mind or something that is biological in nature. The debate stirs because there is not a definitive test, like a blood test, to show that chronic fatigue syndrome exists.
Common among chronic fatigue syndrome patients is intermittent or persistent gut [...]
September 14th, 2007 by Richard Brassaw
The symptoms of bipolar disorder include profound mood swings, from depression to vastly overblown excitement, energy, and elation, often accompanied by severe irritability. Both children and adults are affected by the disorder.
Often the depressive phase of bipolar disorder is thought to be a period when the patient is at risk, but the manic phase has [...]
Category :
Parkinson
0 Comment »
